Starting July 7, 2025, the two highest doses of Zepbound will be available for a flat price of $499 per month, with shipments ...

India has officially approved and launched Mounjaro (tirzepatide), a groundbreaking injectable medication for the treatment of Type 2 diabetes and obesity. Developed by Eli Lilly and Company, the drug ...

has seen its recent launch of single-use tirzepatide vials shift patient practices toward its weight loss drug Zepbound. According to InvestingPro analysis, Lilly maintains a "GREAT" financial ...

The pharmaceutical giant, with a market capitalization of $733.75 billion and an impressive 36.38% revenue growth over the last twelve months, has seen its recent launch of single-use tirzepatide ...

[2] It is available as a lyophilized powder for injection in 10-mL glass vials containing pantoprazole sodium salt (equivalent to 40 mg of pantoprazole) and as 40-mg delayed-release enteric-coated ...